Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Maxime Dely: What If Whole Blood Became the Standard Again in Massive Transfusion?
Maxime Dely/LinkedIn
May 5, 2026, 11:21

Maxime Dely: What If Whole Blood Became the Standard Again in Massive Transfusion?

Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:

“What if whole blood became the standard again in massive transfusion?

In the management of massive hemorrhage, current protocols are well established: alternating red blood cell concentrates, plasma, and platelets – a structured sequence designed to approximate whole blood.

But an important question is increasingly being raised:

Why not use leukoreduced whole blood directly?

The advantages are clear:

  • A product that is inherently complete and balanced
  • Simplified logistics (single storage condition and unified shelf-life considerations)
  • More efficient inventory management

From a scientific standpoint, several recent studies indicate that whole blood offers efficacy comparable to component therapy, particularly regarding early survival and correction of coagulopathy.

Beyond clinical outcomes, this also prompts broader reflection on our organizational models.

And you – have your institutions already begun exploring this shift?”

Maxime Dely: What If Whole Blood Became the Standard Again in Massive Transfusion?

Find more posts featuring Maxime Dely on Hemostasis Today.

Coagulopathy Health Hematology Hemostasis Hemostasis News Hemostasis Today Maxime Dely Medicine Transfusion Medicine
NewsFeed